Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

A randomized controlled trial of lusutrombopag in Japanese patients with chronic liver disease undergoing radiofrequency ablation.

Tateishi R, Seike M, Kudo M, Tamai H, Kawazoe S, Katsube T, Ochiai T, Fukuhara T, Kano T, Tanaka K, Kurokawa M, Yamamoto K, Osaki Y, Izumi N, Imawari M.

J Gastroenterol. 2019 Feb;54(2):171-181. doi: 10.1007/s00535-018-1499-2. Epub 2018 Aug 13.

PMID:
30105510
2.

Retracted: Seropositivity and Titers of Anti-Smooth Muscle Actin Antibody Are Associated with Relapse of Type 1 Autoimmune Hepatitis.

Otsuka T, Isoda H, Araki N, Kubotsu Y, Kawaguchi Y, Nakashita S, Yoshioka W, Kawazoe S, Kawasoe H, Ide Y, Mizuta T; Saga Study Group of Liver Diseases (SASLD), Shibuki T.

Med Sci Monit. 2018 Mar 26 [revised 2018 Jan 1];24:1768. doi: 10.12659/MSM.910003. No abstract available.

3.

Seropositivity and Titers of Anti-Smooth Muscle Actin Antibody Are Associated with Relapse of Type 1 Autoimmune Hepatitis.

Shibuki T, Otsuka T, Isoda H, Araki N, Kubotsu Y, Kawaguchi Y, Nakashita S, Yoshioka W, Kawazoe S, Kawasoe H, Ide Y, Mizuta T, Liver Diseases Sasld SSGO.

Med Sci Monit. 2017 Aug 20;23:4028-4033. Retraction in: Med Sci Monit. 2018 Mar 26;24:1768.

4.

Supplementation with branched-chain amino acids ameliorates hypoalbuminemia, prevents sarcopenia, and reduces fat accumulation in the skeletal muscles of patients with liver cirrhosis.

Kitajima Y, Takahashi H, Akiyama T, Murayama K, Iwane S, Kuwashiro T, Tanaka K, Kawazoe S, Ono N, Eguchi T, Anzai K, Eguchi Y.

J Gastroenterol. 2018 Mar;53(3):427-437. doi: 10.1007/s00535-017-1370-x. Epub 2017 Jul 24.

PMID:
28741271
5.

S-1 versus placebo in patients with sorafenib-refractory advanced hepatocellular carcinoma (S-CUBE): a randomised, double-blind, multicentre, phase 3 trial.

Kudo M, Moriguchi M, Numata K, Hidaka H, Tanaka H, Ikeda M, Kawazoe S, Ohkawa S, Sato Y, Kaneko S, Furuse J, Takeuchi M, Fang X, Date Y, Takeuchi M, Okusaka T.

Lancet Gastroenterol Hepatol. 2017 Jun;2(6):407-417. doi: 10.1016/S2468-1253(17)30072-9. Epub 2017 Apr 6.

PMID:
28497756
6.

Peginterferon Lambda-1a/Ribavirin with Daclatasvir or Peginterferon Alfa-2a/Ribavirin with Telaprevir for Chronic Hepatitis C Genotype 1b.

Flisiak R, Kawazoe S, Znoyko O, Assy N, Gadano A, Kao JH, Lee KS, Zwirtes R, Portsmouth S, Dong Y, Xu D, Kumada H, Srinivasan S.

J Interferon Cytokine Res. 2016 Nov;36(11):635-643. Epub 2016 Jun 21.

PMID:
27327078
7.

Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma.

Ikeda K, Kudo M, Kawazoe S, Osaki Y, Ikeda M, Okusaka T, Tamai T, Suzuki T, Hisai T, Hayato S, Okita K, Kumada H.

J Gastroenterol. 2017 Apr;52(4):512-519. doi: 10.1007/s00535-016-1263-4. Epub 2016 Oct 4.

8.

Ramucirumab as Second-Line Treatment in Patients With Advanced Hepatocellular Carcinoma: Analysis of REACH Trial Results by Child-Pugh Score.

Zhu AX, Baron AD, Malfertheiner P, Kudo M, Kawazoe S, Pezet D, Weissinger F, Brandi G, Barone CA, Okusaka T, Wada Y, Park JO, Ryoo BY, Cho JY, Chung HC, Li CP, Yen CJ, Lee KD, Chang SC, Yang L, Abada PB, Chau I.

JAMA Oncol. 2016 Sep 22. doi: 10.1001/jamaoncol.2016.4115. [Epub ahead of print]

PMID:
27657674
9.

Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma: Japanese subgroup analysis of the REACH trial.

Kudo M, Hatano E, Ohkawa S, Fujii H, Masumoto A, Furuse J, Wada Y, Ishii H, Obi S, Kaneko S, Kawazoe S, Yokosuka O, Ikeda M, Ukai K, Morita S, Tsuji A, Kudo T, Shimada M, Osaki Y, Tateishi R, Sugiyama G, Abada PB, Yang L, Okusaka T, Zhu AX.

J Gastroenterol. 2017 Apr;52(4):494-503. doi: 10.1007/s00535-016-1247-4. Epub 2016 Aug 22.

PMID:
27549242
10.

Impact of Body Weight Reduction via Diet and Exercise on the Anti-Viral Effects of Pegylated Interferon Plus Ribavirin in Chronic Hepatitis C Patients with Insulin Resistance: A Randomized Controlled Pilot Trial.

Iwane S, Mizuta T, Kawaguchi Y, Takahashi H, Oza N, Oeda S, Nakashita S, Kuwashiro T, Otsuka T, Kawazoe S, Eguchi Y, Anzai K, Ozaki I, Fujimoto K.

Intern Med. 2015;54(24):3113-9. doi: 10.2169/internalmedicine.54.5574. Epub 2015 Dec 15.

11.

Efficacy and safety of telaprevir, pegylated interferon α-2b and ribavirin triple therapy in Japanese patients infected with hepatitis C virus genotype 1b.

Kawaguchi Y, Iwane S, Kumagai T, Yanagita K, Yasutake T, Ide Y, Otsuka T, Eguchi Y, Ozaki I, Akiyama T, Kawazoe S, Mizuta T.

Intern Med. 2015;54(20):2551-60. doi: 10.2169/internalmedicine.54.4817. Epub 2015 Oct 15.

12.

[Nicotine dependence].

Kawazoe S, Shinkai T.

Nihon Rinsho. 2015 Sep;73(9):1516-21. Review. Japanese.

PMID:
26394514
13.

Factors Associated with Post-Progression Survival in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib.

Otsuka T, Nakashita S, Yanagita K, Ario K, Kawasoe H, Kawazoe S, Eguchi Y, Mizuta T.

Diseases. 2015 May 15;3(2):68-77. doi: 10.3390/diseases3020068.

14.

Tolvaptan for improvement of hepatic edema: A phase 3, multicenter, randomized, double-blind, placebo-controlled trial.

Sakaida I, Kawazoe S, Kajimura K, Saito T, Okuse C, Takaguchi K, Okada M, Okita K; ASCITES-DOUBLEBLIND Study Group.

Hepatol Res. 2014 Jan;44(1):73-82. doi: 10.1111/hepr.12098. Epub 2013 Apr 3.

PMID:
23551935
15.

Dose-finding trial of tolvaptan in liver cirrhosis patients with hepatic edema: A randomized, double-blind, placebo-controlled trial.

Okita K, Kawazoe S, Hasebe C, Kajimura K, Kaneko A, Okada M, Sakaida I; ASCITES Dose-Finding Trial Group.

Hepatol Res. 2014 Jan;44(1):83-91. doi: 10.1111/hepr.12099. Epub 2013 Mar 27.

PMID:
23530991
16.

Skin toxicities and survival in advanced hepatocellular carcinoma patients treated with sorafenib.

Otsuka T, Eguchi Y, Kawazoe S, Yanagita K, Ario K, Kitahara K, Kawasoe H, Kato H, Mizuta T; Saga Liver Cancer Study Group.

Hepatol Res. 2012 Sep;42(9):879-86. doi: 10.1111/j.1872-034X.2012.00991.x. Epub 2012 Apr 2.

PMID:
22469363
17.

Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial.

Otsuka T, Kawazoe S, Nakashita S, Kamachi S, Oeda S, Sumida C, Akiyama T, Ario K, Fujimoto M, Tabuchi M, Noda T.

J Gastroenterol. 2012 Aug;47(8):912-7. doi: 10.1007/s00535-012-0554-7. Epub 2012 Feb 18.

PMID:
22350703
18.

Effect of vitamin K2 on the recurrence of hepatocellular carcinoma.

Yoshida H, Shiratori Y, Kudo M, Shiina S, Mizuta T, Kojiro M, Yamamoto K, Koike Y, Saito K, Koyanagi N, Kawabe T, Kawazoe S, Kobashi H, Kasugai H, Osaki Y, Araki Y, Izumi N, Oka H, Tsuji K, Toyota J, Seki T, Osawa T, Masaki N, Ichinose M, Seike M, Ishikawa A, Ueno Y, Tagawa K, Kuromatsu R, Sakisaka S, Ikeda H, Kuroda H, Kokuryu H, Yamashita T, Sakaida I, Katamoto T, Kikuchi K, Nomoto M, Omata M.

Hepatology. 2011 Aug;54(2):532-40. doi: 10.1002/hep.24430. Epub 2011 Jun 26.

PMID:
21574174
19.

Body mass index is associated with age-at-onset of HCV-infected hepatocellular carcinoma patients.

Akiyama T, Mizuta T, Kawazoe S, Eguchi Y, Kawaguchi Y, Takahashi H, Ozaki I, Fujimoto K.

World J Gastroenterol. 2011 Feb 21;17(7):914-21. doi: 10.3748/wjg.v17.i7.914.

20.

Efficacy and safety of radiofrequency ablation for elderly hepatocellular carcinoma patients.

Takahashi H, Mizuta T, Kawazoe S, Eguchi Y, Kawaguchi Y, Otuka T, Oeda S, Ario K, Iwane S, Akiyama T, Ozaki I, Fujimoto K.

Hepatol Res. 2010 Oct;40(10):997-1005. doi: 10.1111/j.1872-034X.2010.00713.x.

PMID:
20887335
21.

Recurrent acute pancreatitis caused by a gastric duplication cyst communicating with an aberrant pancreatic duct.

Oeda S, Otsuka T, Akiyama T, Ario K, Masuda M, Taguchi S, Shono T, Kawazoe S.

Intern Med. 2010;49(14):1371-5. Epub 2010 Jul 15.

22.

[Combined estrogenic activity of soybean extract used in a dietary supplement and ethinyl estradiol].

Kawazoe S, Naka K, Ishibashi H, Obara T, Arizono K, Hashimoto K, Hojo Y, Suzuki T.

Shokuhin Eiseigaku Zasshi. 2010;51(3):101-9. Japanese.

23.

Oral administration of acidic xylooligosaccharides prevents the development of atopic dermatitis-like skin lesions in NC/Nga mice.

Ohbuchi T, Sakaino M, Takahashi T, Azumi N, Ishikawa K, Kawazoe S, Kobayashi Y, Kido Y.

J Nutr Sci Vitaminol (Tokyo). 2010;56(1):54-9.

24.

DNA microarray analysis of genomic responses of yeast Saccharomyces cerevisiae to nickel chloride.

Takumi S, Kimura H, Matsusaki H, Kawazoe S, Tominaga N, Arizono K.

J Toxicol Sci. 2010 Feb;35(1):125-9.

25.

Phosphorylase-catalyzed N-formyl-alpha-glucosaminylation of maltooligosaccharides.

Kawazoe S, Izawa H, Nawaji M, Kaneko Y, Kadokawa J.

Carbohydr Res. 2010 Mar 30;345(5):631-6. doi: 10.1016/j.carres.2010.01.001. Epub 2010 Jan 7.

PMID:
20096828
26.

Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population.

Imaizumi T, Higaki Y, Hara M, Sakamoto T, Horita M, Mizuta T, Eguchi Y, Yasutake T, Ozaki I, Yamamoto K, Onohara S, Kawazoe S, Shigematsu H, Koizumi S, Kudo S, Tanaka K.

Carcinogenesis. 2009 Oct;30(10):1729-34. doi: 10.1093/carcin/bgp191. Epub 2009 Jul 30.

PMID:
19643819
27.

Discovery of novel thiourea derivatives as potent and selective beta3-adrenergic receptor agonists.

Maruyama T, Seki N, Onda K, Suzuki T, Kawazoe S, Hayakawa M, Matsui T, Takasu T, Ohta M.

Bioorg Med Chem. 2009 Aug 1;17(15):5510-9. doi: 10.1016/j.bmc.2009.06.031. Epub 2009 Jun 21.

PMID:
19581100
28.

Extrinsic factors derived from mouse embryonal carcinoma cell lines maintain pluripotency of mouse embryonic stem cells through a novel signal pathway.

Kawazoe S, Ikeda N, Miki K, Shibuya M, Morikawa K, Nakano S, Oshimura M, Hisatome I, Shirayoshi Y.

Dev Growth Differ. 2009 Feb;51(2):81-93. doi: 10.1111/j.1440-169X.2008.01082.x.

PMID:
19207180
29.

Interaction between interleukin-1beta -31T/C gene polymorphism and drinking and smoking habits on the risk of hepatocellular carcinoma among Japanese.

Sakamoto T, Higaki Y, Hara M, Ichiba M, Horita M, Mizuta T, Eguchi Y, Yasutake T, Ozaki I, Yamamoto K, Onohara S, Kawazoe S, Shigematsu H, Koizumi S, Tanaka K.

Cancer Lett. 2008 Nov 18;271(1):98-104. doi: 10.1016/j.canlet.2008.05.036. Epub 2008 Jul 7.

PMID:
18603357
30.

Correction of a genetic defect in multipotent germline stem cells using a human artificial chromosome.

Kazuki Y, Hoshiya H, Kai Y, Abe S, Takiguchi M, Osaki M, Kawazoe S, Katoh M, Kanatsu-Shinohara M, Inoue K, Kajitani N, Yoshino T, Shirayoshi Y, Ogura A, Shinohara T, Barrett JC, Oshimura M.

Gene Ther. 2008 Apr;15(8):617-24. doi: 10.1038/sj.gt.3303091. Epub 2008 Feb 28.

PMID:
18305578
31.

Case-control study on cigarette smoking and the risk of hepatocellular carcinoma among Japanese.

Hara M, Tanaka K, Sakamoto T, Higaki Y, Mizuta T, Eguchi Y, Yasutake T, Ozaki I, Yamamoto K, Onohara S, Kawazoe S, Shigematsu H, Koizumi S.

Cancer Sci. 2008 Jan;99(1):93-7. Epub 2007 Oct 22.

32.

High-dose vitamins E and C supplementation prevents ribavirin-induced hemolytic anemia in patients with chronic hepatitis C.

Kawaguchi Y, Mizuta T, Takahashi K, Iwane S, Ario K, Kawasoe H, Hamaoka K, Eguchi Y, Yasutake T, Shigematsu H, Kawazoe S, Fukushima N, Ozaki I, Fujimoto K.

Hepatol Res. 2007 May;37(5):317-24.

PMID:
17441803
33.

Inverse association between coffee drinking and the risk of hepatocellular carcinoma: a case-control study in Japan.

Tanaka K, Hara M, Sakamoto T, Higaki Y, Mizuta T, Eguchi Y, Yasutake T, Ozaki I, Yamamoto K, Onohara S, Kawazoe S, Shigematsu H, Koizumi S.

Cancer Sci. 2007 Feb;98(2):214-8.

34.

hOGG1 Ser326Cys polymorphism and risk of hepatocellular carcinoma among Japanese.

Sakamoto T, Higaki Y, Hara M, Ichiba M, Horita M, Mizuta T, Eguchi Y, Yasutake T, Ozaki I, Yamamoto K, Onohara S, Kawazoe S, Shigematsu H, Koizumi S, Tanaka K.

J Epidemiol. 2006 Nov;16(6):233-9.

35.

A novel dual antagonist of thromboxane A2 and leukotriene D4 receptors: synthesis and structure-activity relationships of chloroquinolylvinyl derivatives.

Okamoto Y, Yokota M, Kawazoe S, Kubota H, Nagaoka H, Arakida Y, Takeuchi M.

Chem Pharm Bull (Tokyo). 2006 May;54(5):603-10.

36.

Clinical outcomes of EMR for gastric tumors: historical pilot evaluation between endoscopic submucosal dissection and conventional mucosal resection.

Watanabe K, Ogata S, Kawazoe S, Watanabe K, Koyama T, Kajiwara T, Shimoda Y, Takase Y, Irie K, Mizuguchi M, Tsunada S, Iwakiri R, Fujimoto K.

Gastrointest Endosc. 2006 May;63(6):776-82.

PMID:
16650537
37.
38.

Influence of alcohol consumption and gene polymorphisms of ADH2 and ALDH2 on hepatocellular carcinoma in a Japanese population.

Sakamoto T, Hara M, Higaki Y, Ichiba M, Horita M, Mizuta T, Eguchi Y, Yasutake T, Ozaki I, Yamamoto K, Onohara S, Kawazoe S, Shigematsu H, Koizumi S, Tanaka K.

Int J Cancer. 2006 Mar 15;118(6):1501-7.

39.

Induction of multiple matrix metalloproteinase genes in human hepatocellular carcinoma by hepatocyte growth factor via a transcription factor Ets-1.

Ozaki I, Mizuta T, Zhao G, Zhang H, Yoshimura T, Kawazoe S, Eguchi Y, Yasutake T, Hisatomi A, Sakai T, Yamamoto K.

Hepatol Res. 2003 Dec;27(4):289-301.

PMID:
14662117
40.

Effects of butyltin compounds on mitochondrial respiration and its relation to hepatotoxicity in mice and Guinea pigs.

Ueno S, Kashimoto T, Susa N, Shiota Y, Okuda M, Mutoh K, Hoshi F, Watanabe K, Tsuda S, Kawazoe S, Suzuki T, Sugiyama M.

Toxicol Sci. 2003 Sep;75(1):201-7. Epub 2003 Jun 12.

PMID:
12805650
41.
42.

Novel malonamide derivatives as alpha v beta 3 antagonists. Syntheses and evaluation of 3-(3-indolin-1-yl-3-oxopropanoyl)aminopropanoic acids on vitronectin interaction with alpha v beta 3.

Nagashima S, Akamatsu S, Kawaminami E, Kawazoe S, Ogami T, Matsumoto Y, Okada M, Suzuki KI, Tsukamoto SI.

Chem Pharm Bull (Tokyo). 2001 Nov;49(11):1420-32.

43.

[A case of percutaneous and transpapillary placements of expandable metallic stents in a patient with cholangiocarcinoma at the hilum of the liver].

Nishida K, Kawazoe S, Higashijima M, Takagi K, Akashi R.

Nihon Ronen Igakkai Zasshi. 2000 Jul;37(7):565-70. Japanese.

44.

In vivo singlet-oxygen generation in blood of chromium(VI)-treated mice: an electron spin resonance spin-trapping study.

Hojo Y, Okado A, Kawazoe S, Mizutani T.

Biol Trace Elem Res. 2000 Jul;76(1):85-93.

PMID:
10999433
45.
47.

[In vivo toxicity, and glutathione, ascorbic acid and copper level changes induced in mouse liver and kidney by copper(II) gluconate, a nutrient supplement].

Hojo Y, Hashimoto I, Miyamoto Y, Kawazoe S, Mizutani T.

Yakugaku Zasshi. 2000 Mar;120(3):311-4. Japanese.

PMID:
10723275
48.

[In vivo toxicity, lipid peroxide lowering, and glutathione, ascorbic acid and copper elevation induced in mouse liver by low dose of oxine-copper, a fungicide].

Hojo Y, Hashimoto I, Miyamoto Y, Kawazoe S, Mizutani T.

Yakugaku Zasshi. 2000 Mar;120(3):307-10. Japanese.

PMID:
10723274
49.

[Hepatotoxicity induction in mice after acute DL-lactic acid intake].

Hojo Y, Matsui K, Watari Y, Kawazoe S, Mizutani T.

Yakugaku Zasshi. 2000 Mar;120(3):304-6. Japanese. Erratum in: Yakugaku Zasshi 2001 Jun;121(6):465.

PMID:
10723273
50.

[An extremely elderly patient with choledocholithiasis and many complications].

Nishida K, Kawazoe S, Higashijima M, Takagi K, Akashi R.

Nihon Ronen Igakkai Zasshi. 1999 Dec;36(12):893-8. Japanese.

Supplemental Content

Loading ...
Support Center